LobbyingPhysicians Committee for Responsible Medicine lobbying by quarter
Physicians Committee for Responsible Medicine's latest lobbying report covers Q2 2026, at $42.2K. The four quarters Q4 2025–Q3 2026 total $154.3K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Animals.
Physicians Committee for Responsible Medicine
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $154.3K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $43.3K | 1 |
| Q1 2023 | $49.9K | 1 |
| Q2 2023 | $58K | 1 |
| Q3 2023 | $43.2K | 1 |
| Q4 2023 | $51.4K | 1 |
| Q1 2024 | $76.7K | 1 |
| Q2 2024 | $121.6K | 2 |
| Q3 2024 | $133.6K | 2 |
| Q4 2024 | $32.3K | 2 |
| Q1 2025 | $53.9K | 2 |
| Q2 2025 | $169.9K | 2 |
| Q3 2025 | $93.6K | 2 |
| Q4 2025 | $72.4K | 1 |
| Q1 2026 | $39.8K | 1 |
| Q2 2026 | $42.2K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$1.1M · 15 reports
- Animals$20K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES21 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-housePhysicians Committee for Responsible Medicine | $1.1M | 15 quarters |
| Brumidi Group | $20K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MADELINE WADE | Special Projects Director, Rep. Greg Walden (7/2012-2/2014) | Q3 2025 |
| CHARLES SPENCER COOPER | Chief of Staff for Rep. Adam Putnam(1/08-11/10); PolicyDir,House Republican Conference(1/07-3/08); StaffDir,Republican Policy Committee(4/06-1/07); Leg Dir,Rep.Mario Diaz-Balart(1/03-4/06);Leg Assistant, Rep.FelixGrucci (10/1-1/03) | Q1 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/16for Q2 | In-house | $42.2K |
| 04/14for Q1 | In-house | $39.8K |
| 01/09for Q4 2025 | In-house | $72.4K |
| 25/11/17for Q3 2025 | Brumidi Group | Under $5,000 |
| 25/10/17for Q3 2025 | In-house | $93.6K |
| 25/07/21for Q2 2025 | Brumidi Group | Under $5,000 |
| 25/07/17for Q2 2025 | In-house | $169.9K |
| 25/04/21for Q1 2025 | Brumidi Group | Under $5,000 |
| 25/04/17for Q1 2025 | In-house | $53.9K |
| 25/04/17for Q1 2025 | In-house | $53.9K |
| 25/01/21for Q4 2024 | Brumidi Group | Under $5,000 |
| 25/01/13for Q4 2024 | In-house | $32.3K |
| 24/10/21for Q3 2024 | Brumidi Group | $10K |
| 24/10/18for Q3 2024 | In-house | $123.6K |
| 24/08/12for Q2 2024 | Brumidi Group | $10K |
| 24/07/17for Q2 2024 | In-house | $111.6K |
| 24/07/16for Q2 2024 | Brumidi Group | Under $5,000 |
| 24/04/12for Q1 2024 | In-house | $76.7K |
| 24/01/17for Q4 2023 | In-house | $51.4K |
| 23/10/13for Q3 2023 | In-house | $43.2K |